These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3689105)

  • 1. Induction of penile erection by intracavernosal injection: a double-blind comparison of phenoxybenzamine versus papaverine-phentolamine versus saline.
    Szasz G; Stevenson RW; Lee L; Sanders HD
    Arch Sex Behav; 1987 Oct; 16(5):371-8. PubMed ID: 3689105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penile function following intracavernosal injection of vasoactive agents or saline.
    Kiely EA; Ignotus P; Williams G
    Br J Urol; 1987 May; 59(5):473-6. PubMed ID: 3594105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double blind, controlled trial.
    Keogh EJ; Earle CM; Carati CJ; Wisniewski ZS; Tulloch AG; Lord DJ; Watters GR
    Aust N Z J Med; 1989 Apr; 19(2):108-12. PubMed ID: 2669713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M; Schramek P
    J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernous injection of vasoactive drugs in the rabbit.
    Stackl W; Loupal G; Holzmann A
    Urol Res; 1988; 16(6):455-8. PubMed ID: 3232278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
    Allen RP; Engel RM; Smolev JK; Brendler CB
    J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Chao R; Clowers DE
    Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
    Hadzija BW; Mattocks AM; Stahl GM
    J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
    Keogh EJ; Watters GR; Earle CM; Carati CJ; Wisniewski ZS; Tulloch GS; Lord DJ
    J Urol; 1989 Sep; 142(3):726-8. PubMed ID: 2671414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
    Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H
    J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection.
    Brindley GS
    Br J Psychiatry; 1986 Aug; 149():210-5. PubMed ID: 3640652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on intracavernosal VIP levels during pharmacologically induced penile erections.
    Kiely EA; Blank MA; Bloom SR; Williams G
    Br J Urol; 1987 Apr; 59(4):334-9. PubMed ID: 2437991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved vasoactive drug combination for a pharmacological erection program.
    Bennett AH; Carpenter AJ; Barada JH
    J Urol; 1991 Dec; 146(6):1564-5. PubMed ID: 1719248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with buccal phentolamine mesylate for impotence.
    Zorgniotti AW
    Int J Impot Res; 1994 Mar; 6(1):37-41. PubMed ID: 7517275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.